Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence.

By Jingwei Xue, Zekai Zhao, Lei Zhang, Lingjing Xue, Shiyang Shen, Yajing Wen, Zhuoyuan Wei, Lu Wang, L. Kong, Hongbin Sun and 3 more. Nature Nanotechnology, 2017

830 citations recorded by the source corpus.

Subfields: Biomedical Engineering, Immunology

View Paper: https://www.semanticscholar.org/paper/2faea7e68bc6fbb8150334e3e8752c6b42bd2971

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. N. Muangsin
2. Feng Han
3. Xiaojie Chen
4. Yajun Wang
5. T. Gong
6. Zhong Chen
7. Di Wu
8. Yi Wang

Citations in the corpus

• Nanomedicine in cancer therapy (2023, background): “116 Moreover, neutrophil-mediated transport has been shown to be more crucial for short-circulating magnetic nanoparticles than their long-circulating counterparts to achieve active tumor targeting.”
• The blood–brain barrier: Structure, regulation and drug delivery (2023, background): “364 The camou fl aged delivery system maintained the physiological features, which could ef fi ciently traverse BBB and migrate to in fl ammatory sites such as tumor parenchyma.”
• Current Challenges and Opportunities in Treating Glioblastoma (2018, background): “A novel cell-based drug delivery system takes advantage of postoperative inflammatory signals such as IL-8 and CXCL1/KC to deliver paclitaxel in neutrophils to GBM tumors (Xue et al., 2017).”